These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33481864)

  • 1. A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    Allman R; Spaeth E; Lai J; Gross SJ; Hopper JL
    PLoS One; 2021; 16(1):e0245375. PubMed ID: 33481864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
    Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
    JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
    Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
    Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
    Gettler K; Levantovsky R; Moscati A; Giri M; Wu Y; Hsu NY; Chuang LS; Sazonovs A; Venkateswaran S; Korie U; Chasteau C; ; Duerr RH; Silverberg MS; Snapper SB; Daly MJ; McGovern DP; Brant SR; Rioux JD; Kugathasan S; Anderson CA; Itan Y; Cho JH
    Gastroenterology; 2021 Apr; 160(5):1546-1557. PubMed ID: 33359885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancestry effects on type 2 diabetes genetic risk inference in Hispanic/Latino populations.
    Chande AT; Rishishwar L; Conley AB; Valderrama-Aguirre A; Medina-Rivas MA; Jordan IK
    BMC Med Genet; 2020 Jun; 21(Suppl 2):132. PubMed ID: 32580712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
    Collister JA; Liu X; Littlejohns TJ; Cuzick J; Clifton L; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):812-820. PubMed ID: 38630597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
    Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG
    Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
    Shieh Y; Fejerman L; Lott PC; Marker K; Sawyer SD; Hu D; Huntsman S; Torres J; Echeverry M; Bohórquez ME; Martínez-Chéquer JC; Polanco-Echeverry G; Estrada-Flórez AP; ; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Vidaurre T; Weitzel JN; Zambrano SC; Carvajal-Carmona LG; Ziv E; Neuhausen SL
    J Natl Cancer Inst; 2020 Jun; 112(6):590-598. PubMed ID: 31553449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
    Evans DG; van Veen EM; Byers H; Roberts E; Howell A; Howell SJ; Harkness EF; Brentnall A; Cuzick J; Newman WG
    Int J Cancer; 2022 Jan; 150(1):73-79. PubMed ID: 34460111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNPs and breast cancer risk prediction for African American and Hispanic women.
    Allman R; Dite GS; Hopper JL; Gordon O; Starlard-Davenport A; Chlebowski R; Kooperberg C
    Breast Cancer Res Treat; 2015 Dec; 154(3):583-9. PubMed ID: 26589314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Estrogen-Related Polygenetic Risk Scores with Breast Cancer and Interactions with Alcohol Intake, Early Menarche, and Nulligravida.
    Song SS; Kang S; Park S
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):13-24. PubMed ID: 35092367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk scores for prediction of breast cancer in Korean women.
    Jee YH; Ho WK; Park S; Easton DF; Teo SH; Jung KJ; Kraft P
    Int J Epidemiol; 2023 Jun; 52(3):796-805. PubMed ID: 36343017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women.
    Hou C; Xu B; Hao Y; Yang D; Song H; Li J
    BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
    McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
    Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.